

Roll over image to zoom in
Hepcinat-LP (HARVONI) ledipasvir/sofosbuvir online
$217.00
Status: In stock
A fixed-dose combination of sofosbuvir 400 mg and ledipasvir 90 mg indicated for the treatment of chronic hepatitis C virus infection.
Ā
Hepcinat-LP, also known as āHARVONIĀ®, Hepcvilr L, Myhep lvirā is a fixed-dose combination of Sofosbuvir and LedipasvirĀ indicated for the treatmentĀ of chronic hepatitis C virus (HCV). Hepcinat-LP combinesĀ Sofosbuvir 400mgĀ andĀ Ledipasvir90mg. Its Cure rates is 94% to 99%Ā for hepatitis C. Sofosbuvir 100mg/Velpatasvir 40 mgās brand name isĀ HARVONIĀ® by Gilead. Hepcinat-LPĀ is a generic oncologic prescription medicine from Natco, which is one of the biggest pharmaceutical company in India.
Ā
Hepcinat-LP, also known as āHARVONIĀ®, Hepcvilr L, Myhep lvirā is a fixed-dose combination of Sofosbuvir and LedipasvirĀ indicated for the treatmentĀ of chronic hepatitis C virus (HCV). Hepcinat-LP combinesĀ Sofosbuvir 400mgĀ andĀ Ledipasvir90mg. Its Cure rates is 94% to 99%Ā for hepatitis C. Sofosbuvir 100mg/Velpatasvir 40 mgās brand name isĀ HARVONIĀ® by Gilead. Hepcinat-LPĀ is a generic oncologic prescription medicine from Natco, which is one of the biggest pharmaceutical company in India.
Ā













